STOCK TITAN

Bio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Bio-Rad Laboratories, a leader in life science research and clinical diagnostics, announced that CEO Norman Schwartz and CFO Roop K. Lakkaraju will participate in a fireside chat at the Jefferies Global Healthcare Conference. The event is scheduled for June 6, 2024, at 10:30 AM ET (7:30 AM PT). A live webcast and replay will be accessible via the Investor Relations section of Bio-Rad’s website.

Positive
  • CEO Norman Schwartz and CFO Roop K. Lakkaraju's participation increases visibility and engagement with investors.
  • The event at Jefferies Global Healthcare Conference highlights Bio-Rad's presence in the healthcare sector.
  • Availability of live webcast and replay ensures broader access for investors and stakeholders.
Negative
  • No new products or financial updates were announced in the press release.
  • The announcement lacks detailed information on expected financial performance or upcoming projects.

HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Executive Officer Norman Schwartz and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during the Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 10:30 AM Eastern Time (7:30 AM Pacific Time).

A live webcast and subsequent replay of the event will be available in the Investor Relations section of Bio-Rad’s website at bio-rad.com.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 8,000 employees and $2.7 billion in revenues in 2023. Our customers include universities, research institutions, hospitals, food safety and environmental quality laboratories, and biopharmaceutical companies. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit bio-rad.com.

Investor Contact:

Edward Chung, Investor Relations

510-741-6104

ir@bio-rad.com

Media Contact:

Anna Gralinska, Corporate Communications

510-741-6643

cc@bio-rad.com

Source: Bio-Rad Laboratories, Inc.

FAQ

When will Bio-Rad’s management participate in the Jefferies Global Healthcare Conference?

Bio-Rad’s management will participate on Thursday, June 6, 2024, at 10:30 AM Eastern Time.

Who will represent Bio-Rad at the Jefferies Global Healthcare Conference?

CEO Norman Schwartz and CFO Roop K. Lakkaraju will represent Bio-Rad.

How can I watch the Bio-Rad fireside chat at the Jefferies Global Healthcare Conference?

A live webcast and subsequent replay will be available on Bio-Rad’s Investor Relations website.

What is the significance of Bio-Rad’s participation in the Jefferies Global Healthcare Conference?

The participation enhances visibility and engagement with investors, highlighting Bio-Rad's presence in the healthcare sector.

Where can I find the replay of Bio-Rad’s management fireside chat?

The replay will be available on Bio-Rad’s Investor Relations section on their website.

Bio-Rad Laboratories, Inc.

NYSE:BIO

BIO Rankings

BIO Latest News

BIO Stock Data

9.24B
22.92M
15.58%
83.25%
2.94%
Medical Devices
In Vitro & in Vivo Diagnostic Substances
Link
United States of America
IRVINE